169 related articles for article (PubMed ID: 37720994)
1. Utilization of an Automated Latex Agglutination Turbidity Assay for Assessing Gastric Mucosal Alteration during
Khangai A; Akada J; Saruuljavkhlan B; Gantuya B; Azzaya D; Oyuntsetseg K; Davaadorj D; Uchida T; Matsumoto T; Yamaoka Y
Gut Liver; 2024 Jan; 18(1):60-69. PubMed ID: 37720994
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
Paik CN; Chung IS; Nam KW; Kwon JH; Chang JH; Suh JP; Park JM; Cho YK; Lee IS; Kim SW; Choi MG
Korean J Gastroenterol; 2007 Aug; 50(2):84-91. PubMed ID: 17928751
[TBL] [Abstract][Full Text] [Related]
4. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
5. Type I and type II
Yuan L; Zhao JB; Zhou YL; Qi YB; Guo QY; Zhang HH; Khan MN; Lan L; Jia CH; Zhang YR; Ding SZ
World J Gastroenterol; 2020 Jul; 26(25):3673-3685. PubMed ID: 32742135
[TBL] [Abstract][Full Text] [Related]
6. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
[TBL] [Abstract][Full Text] [Related]
7. Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study.
Chiang TH; Chen YN; Chen YR; Tseng YH; Shieh CF; Liu CY; Chiu HM; Chiang H; Shun CT; Wu MS; Lin JT; Lee YC
BMC Gastroenterol; 2022 Feb; 22(1):69. PubMed ID: 35180851
[TBL] [Abstract][Full Text] [Related]
8. Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer.
Yamada S; Kato S; Matsuhisa T; Makonkawkeyoon L; Yoshida M; Chakrabandhu T; Lertprasertsuk N; Suttharat P; Chakrabandhu B; Nishiumi S; Chongraksut W; Azuma T
World J Gastroenterol; 2013 May; 19(19):2941-9. PubMed ID: 23704827
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.
Kitamura Y; Yoshihara M; Ito M; Boda T; Matsuo T; Kotachi T; Tanaka S; Chayama K
J Gastroenterol Hepatol; 2015 Oct; 30(10):1473-7. PubMed ID: 25974661
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
11. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.
Sato Y; Iwafuchi M; Ueki J; Yoshimura A; Mochizuki T; Motoyama H; Sugimura K; Honma T; Narisawa R; Ichida T; Asakura H; Van Thiel DH
Dig Dis Sci; 2002 Mar; 47(3):579-85. PubMed ID: 11911346
[TBL] [Abstract][Full Text] [Related]
12. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
13. Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea.
Kim HY; Kim N; Kang JM; Park YS; Lee DH; Kim YR; Kim JS; Jung HC; Song IS
Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):606-12. PubMed ID: 19293719
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis.
Liu W; Tian J; Hui W; Kong W; Feng Y; Si J; Gao F
Sci Rep; 2021 Feb; 11(1):4143. PubMed ID: 33603125
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
16. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
17. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
[TBL] [Abstract][Full Text] [Related]
18. Serum pepsinogen and Helicobacter pylori infection--a Japanese population study.
Toyoda K; Furusyo N; Ihara T; Ikezaki H; Urita Y; Hayashi J
Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2117-24. PubMed ID: 22354521
[TBL] [Abstract][Full Text] [Related]
19. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
[TBL] [Abstract][Full Text] [Related]
20. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY
Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
